Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studies. - Wikidata - wikimedia - TriplyDB

Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studies.

Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studies.

http://www.wikidata.org/entity/Q37396577

about

Human iPSC for Therapeutic Approaches to the Nervous System: Present and Future Applications Neural Stem Cell Carriers for the Treatment of Glioblastoma Multiforme Sui generis: gene therapy and delivery systems for the treatment of glioblastoma Training stem cells for treatment of malignant brain tumors Novel strategies in glioblastoma surgery aim at safe, supra-maximum resection in conjunction with local therapies Stem cell mechanisms during left ventricular remodeling post-myocardial infarction: Repair and regeneration Hypoxia-cultured human adipose-derived mesenchymal stem cells are non-oncogenic and have enhanced viability, motility, and tropism to brain cancer.Therapeutically engineered induced neural stem cells are tumour-homing and inhibit progression of glioblastoma.Sustained radiosensitization of hypoxic glioma cells after oxygen pretreatment in an animal model of glioblastoma and in vitro models of tumor hypoxia.Controlled Payload Release by Magnetic Field Triggered Neural Stem Cell Destruction for Malignant Glioma Treatment Drug delivery strategies to enhance the permeability of the blood-brain barrier for treatment of glioma Electrospun nanofibrous scaffolds increase the efficacy of stem cell-mediated therapy of surgically resected glioblastoma.Clinical applications of iron oxide nanoparticles for magnetic resonance imaging of brain tumors.Neural stem cell therapy for cancer.Stem cell based gene therapy in prostate cancer Prodrug applications for targeted cancer therapy.Conjugation of pH-responsive nanoparticles to neural stem cells improves intratumoral therapy.Dihydropyrimidine Dehydrogenase Is a Prognostic Marker for Mesenchymal Stem Cell-Mediated Cytosine Deaminase Gene and 5-Fluorocytosine Prodrug Therapy for the Treatment of Recurrent Gliomas.Neural stem cell-mediated intratumoral delivery of gold nanorods improves photothermal therapy.Human cerebrospinal fluid regulates proliferation and migration of stem cells through insulin-like growth factor-1.Analysis of glioblastoma tumor coverage by oncolytic virus-loaded neural stem cells using MRI-based tracking and histological reconstruction.Oncolytic adenoviruses: A thorny path to glioma cure Increased sensitivity of glioma cells to 5-fluorocytosine following photo-chemical internalization enhanced nonviral transfection of the cytosine deaminase suicide gene Systemic anticancer neural stem cells in combination with a cardiac glycoside for glioblastoma therapy Nanoparticles for Targeting Intratumoral Hypoxia: Exploiting a Potential Weakness of Glioblastoma.Exogenous marker-engineered mesenchymal stem cells detect cancer and metastases in a simple blood assay.Neural Stem Cells Secreting Anti-HER2 Antibody Improve Survival in a Preclinical Model of HER2 Overexpressing Breast Cancer Brain Metastases.MMP14 as a novel downstream target of VEGFR2 in migratory glioma-tropic neural stem cells.Superparamagnetic iron oxide nanoparticles for direct labeling of stem cells and in vivo MRI tracking.Genetically engineered theranostic mesenchymal stem cells for the evaluation of the anticancer efficacy of enzyme/prodrug systems.Fibrin matrices enhance the transplant and efficacy of cytotoxic stem cell therapy for post-surgical cancer.Magnetic resonance imaging tracking of ferumoxytol-labeled human neural stem cells: studies leading to clinical use.L-MYC Expression Maintains Self-Renewal and Prolongs Multipotency of Primary Human Neural Stem Cells Neural stem cell-mediated delivery of irinotecan-activating carboxylesterases to glioma: implications for clinical use.Hematopoietic stem cells as a tool for the treatment of glioblastoma multiforme.Targeted Inhibition of the miR-199a/214 Cluster by CRISPR Interference Augments the Tumor Tropism of Human Induced Pluripotent Stem Cell-Derived Neural Stem Cells under Hypoxic Condition.Nanoparticle engineered TRAIL-overexpressing adipose-derived stem cells target and eradicate glioblastoma via intracranial delivery.Glioma virus therapies between bench and bedside.Optimization of a Neural Stem-Cell-Mediated Carboxylesterase/Irinotecan Gene Therapy for Metastatic Neuroblastoma.Strategies to increase drug penetration in solid tumors.

P2860

Q26772309-A48A95B6-F2BA-45D9-8BDA-9BB6FE55F4B0 Q26783167-C35E08FE-CB63-4841-9E0C-4589DE9E1E98 Q26850467-7D001607-B38E-4648-A94E-913E67A895D4 Q27006790-F6F31EFB-ABF3-4792-B34C-C89A7C20A09D Q27023618-E8ED8895-9536-4EE6-B950-1830821FC479 Q27026285-6AD0F801-1556-4D13-8F3F-B607DE0DAE94 Q27330583-E5E04A06-22C3-45F3-B5FB-8D80DCF40B10 Q27333831-2AF38B7E-6DD1-4206-A611-F13C7AC4468D Q27334035-BB430950-9E8B-4BE9-AF54-D1660B647CEF Q28552160-52DCCC46-930D-4A1B-8FF3-6A492A2FCCC0 Q30413487-2421BB56-936A-48E3-A70B-8A14B632DEF1 Q30843565-52AB99A4-7A95-4A56-A8A7-2DEDDB746762 Q30930526-065A7944-A503-48EF-89CB-AD70752BE5F1 Q33704489-BC3A5F9C-30FE-48D0-A4A8-A81D08B796A9 Q33997951-A30EFAE4-0005-4320-929A-5EC63AA24EFA Q34099780-6EE56F38-2637-4DC6-B93D-4474385BDA28 Q34145424-B975DF68-7AC3-4FB1-ACF9-9609865155AF Q34534990-DD67FB9C-ADC2-458A-ABF8-0221196AA78D Q34782994-A0F4F1FF-EBF7-4A1C-9122-66932C620B3B Q34920315-9184863F-DDD6-4B9D-B15E-D652E0F57664 Q34943738-77DEAC72-EC70-4DAF-B7F4-9B5FFC740C1F Q35077747-30098A77-6C79-4A6A-B1C2-9345DB3FA656 Q35115061-33771D2A-5937-42DF-8860-AEA4ADA979C3 Q35679830-D77FD120-31C4-425C-9A52-43B3097BEEFC Q36031889-D824D849-8107-4226-B0B8-3159CF51A335 Q36082553-C8D7CD5E-28AC-497C-98B0-B408CCBC9BF0 Q36083446-B258035A-2E9A-4332-8510-55FE0E90EB71 Q36421256-19052A9B-BDEF-49CB-AB77-2E26F1999D16 Q36510497-52F50BF0-FAD1-4AB6-AD10-004E8EC9BE2D Q36592690-323A0F06-15EF-4629-AA28-256C854C04CB Q36684365-E6FC1F6B-5024-4E01-B04C-AA1EA948C531 Q37202723-740F62AD-CA19-4686-B71F-5A1B9EFB2A92 Q37274084-9B9E86C3-28F8-4492-A53B-089A30E190DB Q37344283-08370DB2-D70E-48AA-B639-28E69B578D8F Q37403493-93BDAA24-AF27-48C2-8294-3E5B546635BE Q37443725-2E149872-39DA-4FD8-9592-DCF2330E8191 Q37473651-140373A9-1634-462D-BEAE-EF96708BCD95 Q37580510-158E2F0A-8072-492C-A506-32377C908C69 Q37718554-7EFFAF13-9E21-4FAC-849E-D81F3D640EEF Q38125197-A3833756-3B12-4DB2-A67C-31E7DF43A842

P2860

Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studies.

http://www.wikidata.org/entity/Q37396577

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studies.

@en

Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studies.

@nl

type

label

Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studies.

@en

Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studies.

@nl

prefLabel

Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studies.

@en

Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studies.

@nl

P1433

Q37396577-70881A24-E048-415B-8E83-82D63E148404

P1476

Q37396577-9C2E5755-F318-4A86-AC70-AEDC98AC778A

P2093

Q37396577-0A4369B1-BC32-4FBC-B4E1-A44DCA188857

Q37396577-0C8FC190-BB54-428B-8E9F-DE4AE074576A

Q37396577-0F2C06F5-F703-444F-BE2F-9D0641EDC29B

Q37396577-12C12362-22C3-4B3D-8E90-B1938F9649DF

Q37396577-24F12902-E05D-467D-A913-1182AF538C3B

Q37396577-2846A970-185F-4512-B876-C726E600E45E

Q37396577-2CC8007E-148E-428E-AF9B-4BA7DCF65A9F

Q37396577-49C671AA-73A7-4C85-8F5C-83AA90D45BC8

Q37396577-4BA40A93-9350-4651-87F7-03EF669146CC

Q37396577-50FE971E-C32D-448A-9FDC-0BF5246AF7FD

P2860

Q37396577-010397FF-4A2F-4506-8D0D-D20969074F67

Q37396577-0265CFE5-2D26-4C55-8455-5DA6B371D890

Q37396577-02EB5D33-E022-4AC3-87D8-76BC3631A82E

Q37396577-08A57078-09EE-4E62-B5B2-78DAF1D0D50F

Q37396577-0D6A1EB6-E09C-41ED-AFEB-74CA6BFFDBD4

Q37396577-0E2BC8E5-8005-42ED-A697-5DA6D0130548

Q37396577-1308652C-1F77-442A-ABAC-3B03824B27DA

Q37396577-136B3C6A-7EFD-456C-97B3-BA0EB3DF4EB1

Q37396577-18ED7FF9-01F9-4B2E-B21E-69B3E5473E9D

Q37396577-1C21CC12-B099-4490-87B4-927AEA69A4A6

P304

Q37396577-F93F2A6E-A910-41A5-854A-DA26E5E580B3

P31

Q37396577-15298F80-0551-429A-965E-5E89A490AAB5

P356

Q37396577-68B45EE7-9208-4C9F-8F29-53C93449A9AD

P407

Q37396577-C234C2F4-EB82-4DB2-A4A4-EC76B0609E43

P433

Q37396577-F63C42DA-D997-4C25-8B91-8EA0B9330F6B

P478

Q37396577-45F58F92-2AD3-424E-A0CF-0CB48E0B5A2D

P577

Q37396577-CDE7205A-6F31-4F55-A1F0-78E7694599A6

P5875

Q37396577-6DA25546-6C95-4223-882E-561F1C4BE72F

P698

Q37396577-405D174F-1E0D-4126-B5E8-3AF853E29217

P932

Q37396577-D0074728-8E7E-4E32-9CE6-5F7A62C85CDD

P356

SCITRANSLMED.3005365

P1433

Science Translational Medicine

P1476

Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studies.

@en

P2093

Alexander J Annala

http://www.w3.org/2001/XMLSchema#string

Behnam Badie

http://www.w3.org/2001/XMLSchema#string

Christine E Brown

http://www.w3.org/2001/XMLSchema#string

Elizabeth Garcia

http://www.w3.org/2001/XMLSchema#string

Jana Portnow

http://www.w3.org/2001/XMLSchema#string

Joseph Najbauer

http://www.w3.org/2001/XMLSchema#string

Karen S Aboody

http://www.w3.org/2001/XMLSchema#string

Larry A Couture

http://www.w3.org/2001/XMLSchema#string

Margarita Gutova

http://www.w3.org/2001/XMLSchema#string

Marianne Z Metz

http://www.w3.org/2001/XMLSchema#string

P2860

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Drug penetration in solid tumours

Malignant gliomas in adults

Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence.

Neural stem cells as a novel platform for tumor-specific delivery of therapeutic antibodies.

Impaired cognitive function and hippocampal neurogenesis following cancer chemotherapy.

Neural stem cell-mediated CE/CPT-11 enzyme/prodrug therapy in transgenic mouse model of intracerebellar medulloblastoma.

Concise review: stem cells as an emerging platform for antibody therapy of cancer.

Early toxicity predicts long-term survival in high-grade glioma.

P304

184ra59

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCITRANSLMED.3005365

http://www.w3.org/2001/XMLSchema#string

P407

P433

184

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2013-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236666332

http://www.w3.org/2001/XMLSchema#string

P698

23658244

http://www.w3.org/2001/XMLSchema#string

P932

3864887

http://www.w3.org/2001/XMLSchema#string